The roles and mechanisms of G3BP1 in tumour promotion

J Drug Target. 2019 Mar;27(3):300-305. doi: 10.1080/1061186X.2018.1523415. Epub 2018 Oct 3.

Abstract

Ras-GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) is a SH3 domain-binding protein that is overexpressed in a variety of tumour tissues and cancers, such as head and neck cancer, lung cancer, prostate cancer, colon cancer and breast cancer. G3BP1 promotes tumour cell proliferation and metastasis and inhibits apoptosis by regulating the Ras, TGF-β/Smad, Src/FAK and p53 signalling pathways. At present, polypeptides targeting G3BP1 have shown anti-tumour activity and G3BP1 also involved in anti-cancer effects of some polyphenolic compounds (resveratrol and EGCG). Therefore G3BP1 may be a potential target for tumour treatment.

Keywords: Ras-GTPase-activating protein SH3 domain-binding protein 1; anti-cancer therapy; apoptosis; metastasis; polyphenolic compounds; tumour.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / physiology
  • Cell Proliferation / physiology
  • DNA Helicases / metabolism*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Peptides / pharmacology
  • Poly-ADP-Ribose Binding Proteins / metabolism*
  • Polyphenols / pharmacology
  • RNA Helicases / metabolism*
  • RNA Recognition Motif Proteins / metabolism*

Substances

  • Antineoplastic Agents
  • Peptides
  • Poly-ADP-Ribose Binding Proteins
  • Polyphenols
  • RNA Recognition Motif Proteins
  • DNA Helicases
  • G3BP1 protein, human
  • RNA Helicases